Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.
Wild D; Christ E; Caplin ME; Kurzawinski TR; Forrer F; Brändle M; Seufert J; Weber WA; Bomanji J; Perren A; Ell PJ; Reubi JC; Journal Of Nuclear Medicine: Official Publication, Society Of Nuclear Medicine, 2011, vol. 52, issue 7, p 1073, ISSN 15355667. ISBN 15355667.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef